Acer Therapeutics Stock (NASDAQ: ACER)
|Day Range1.36 - 1.48||52 Wk Range1.16 - 3.77||Open / Close1.41 / 1.39||Float / Outstanding11.2M / 16.1M|
|Vol / Avg.43.6K / 100.6K||Mkt Cap22.4M||P/E-||50d Avg. Price1.45|
|Div / Yield-||Payout Ratio-||Total Float11.2M||EPS-0.17|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Acer Therapeutics (NASDAQ: ACER) through any online brokerage.
The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by EF Hutton on Wednesday, February 2, 2022. The analyst firm set a price target for 9.00 expecting ACER to rise to within 12 months (a possible 547.48% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Acer Therapeutics (NASDAQ: ACER) is $1.39 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Acer Therapeutics.
Acer Therapeutics’s Q3 earnings are confirmed for Friday, November 18, 2022.
There is no upcoming split for Acer Therapeutics.
Acer Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.